| Zhong, Lin |
NCT03331744: Clinical Characteristics of Infantile Hemangioma |
|
|
| Recruiting | N/A | 1000 | RoW | | West China Hospital | Hemangioma | 12/25 | 12/25 | | |
NCT06201754: Bedside Air Quality in ICU and Clinical Outcome |
|
|
| Recruiting | N/A | 600 | RoW | Measure air quality | First Affiliated Hospital of Zhejiang University | Critical Illness | 05/25 | 05/25 | | |
| Recruiting | N/A | 250 | RoW | metagenomics | First Affiliated Hospital of Zhejiang University | Multidrug Resistant Bacterial Infection | 01/25 | 06/25 | | |
NCT06365502: Preventive Drug-coated Balloon Angioplasty in Vulnerable Atherosclerotic Plaque (RESTORE Trial) |
|
|
| Recruiting | N/A | 1860 | RoW | Drug-coated balloon, Guideline-directed medical treatment | Harbin Medical University, Shanghai Shenqi Medical Technology Co., Ltd | Acute Coronary Syndrome (ACS) | 12/27 | 12/30 | | |
MASS, NCT06114784: Microbiome and Host Susceptibility in Severe Pneumonia, a Prospective, Multicenter, Cohort Study |
|
|
| Recruiting | N/A | 2000 | RoW | Metagenomics | First Affiliated Hospital of Zhejiang University | Severe Pneumonia | 12/25 | 12/25 | | |
| Not yet recruiting | N/A | 100 | RoW | NAS, NGS and Laboratory tests | Shenzhen Third People's Hospital | Liver Transplant Infection | 08/26 | 10/26 | | |
NCT05448339: Tumor Feeding Vessels Deprivation Combined With Tyrosine Kinase Inhibitor in Liver Transplantation |
|
|
| Completed | N/A | 197 | RoW | PVHA or TACE | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Liver Transplantation | 12/23 | 01/24 | | |
NCT04995159: Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVasâ„¢ BRS System |
|
|
| Not yet recruiting | N/A | 2150 | RoW | Single anti-platelet therapy, SAPT strategy, Dual anti-platelet therapy, DAPT strategy | Lepu Medical Technology (Beijing) Co., Ltd. | Coronary Heart Disease | 01/26 | 01/28 | | |
